Boxer Capital as of Sept. 30, 2022
Portfolio Holdings for Boxer Capital
Boxer Capital holds 73 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 7.9 | $140M | 2.0M | 69.84 | |
| Cytokinetics Com New (CYTK) | 5.7 | $102M | 2.1M | 48.45 | |
| Prometheus Biosciences | 5.7 | $101M | 1.7M | 59.01 | |
| Springworks Therapeutics (SWTX) | 5.5 | $98M | 3.4M | 28.53 | |
| Apellis Pharmaceuticals (APLS) | 5.0 | $89M | 1.3M | 68.30 | |
| Revolution Medicines (RVMD) | 4.4 | $79M | 4.0M | 19.72 | |
| Beigene Sponsored Adr (ONC) | 3.8 | $67M | 500k | 134.82 | |
| Amylyx Pharmaceuticals (AMLX) | 3.3 | $59M | 2.1M | 28.15 | |
| Tyra Biosciences (TYRA) | 3.2 | $57M | 6.4M | 8.79 | |
| Relay Therapeutics (RLAY) | 2.7 | $49M | 2.2M | 22.37 | |
| Sage Therapeutics (SAGE) | 2.4 | $43M | 1.1M | 39.16 | |
| Gossamer Bio (GOSS) | 2.4 | $43M | 3.6M | 11.98 | |
| Iteos Therapeutics | 2.3 | $41M | 2.2M | 19.05 | |
| Merus N V (MRUS) | 2.1 | $38M | 1.9M | 20.03 | |
| Pmv Pharmaceuticals (PMVP) | 2.1 | $38M | 3.2M | 11.90 | |
| Arcus Biosciences Incorporated (RCUS) | 2.1 | $38M | 1.4M | 26.16 | |
| Bellus Health Com New | 1.9 | $34M | 3.2M | 10.56 | |
| Anaptysbio Inc Common (ANAB) | 1.9 | $33M | 1.3M | 25.51 | |
| Ideaya Biosciences (IDYA) | 1.8 | $33M | 2.2M | 14.92 | |
| Reata Pharmaceuticals Cl A | 1.8 | $31M | 1.2M | 25.13 | |
| Ventyx Biosciences (VTYX) | 1.7 | $30M | 850k | 34.91 | |
| Female Health (VERU) | 1.6 | $29M | 2.5M | 11.52 | |
| Akero Therapeutics (AKRO) | 1.6 | $28M | 832k | 34.05 | |
| Tango Therapeutics (TNGX) | 1.4 | $25M | 6.9M | 3.62 | |
| Amicus Therapeutics (FOLD) | 1.4 | $24M | 2.3M | 10.44 | |
| Day One Biopharmaceuticals I (DAWN) | 1.3 | $24M | 1.2M | 20.03 | |
| Nuvalent Inc-a (NUVL) | 1.3 | $24M | 1.2M | 19.44 | |
| Rocket Pharmaceuticals (RCKT) | 1.3 | $23M | 1.5M | 15.96 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $22M | 200k | 110.54 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $22M | 600k | 36.10 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $21M | 1.3M | 16.36 | |
| Exelixis (EXEL) | 1.1 | $20M | 1.3M | 15.68 | |
| Point Biopharma Global | 1.1 | $19M | 2.5M | 7.73 | |
| Iovance Biotherapeutics (IOVA) | 1.0 | $19M | 1.9M | 9.58 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $18M | 1.1M | 16.33 | |
| Kinnate Biopharma | 1.0 | $18M | 1.5M | 11.95 | |
| Prothena Corp SHS (PRTA) | 1.0 | $18M | 300k | 60.63 | |
| Blueprint Medicines (BPMC) | 1.0 | $18M | 275k | 65.89 | |
| Nurix Therapeutics (NRIX) | 0.9 | $16M | 1.2M | 13.03 | |
| Cullinan Oncology (CGEM) | 0.8 | $14M | 1.1M | 12.82 | |
| Third Harmonic Bio (THRD) | 0.6 | $11M | 570k | 18.97 | |
| 89bio (ETNB) | 0.5 | $8.1M | 1.4M | 5.79 | |
| Fate Therapeutics (FATE) | 0.4 | $7.8M | 350k | 22.41 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $7.2M | 70k | 103.26 | |
| 2seventy Bio Common Stock | 0.4 | $6.7M | 460k | 14.55 | |
| Ngm Biopharmaceuticals | 0.4 | $6.5M | 500k | 13.08 | |
| Milestone Pharmaceuticals (MIST) | 0.4 | $6.4M | 699k | 9.19 | |
| Altimmune Com New (ALT) | 0.4 | $6.4M | 500k | 12.77 | |
| Cogent Biosciences (COGT) | 0.4 | $6.3M | 425k | 14.92 | |
| Rain Therapeutics | 0.3 | $5.7M | 1.2M | 4.88 | |
| Selecta Biosciences | 0.3 | $5.4M | 3.3M | 1.64 | |
| Bioatla (BCAB) | 0.3 | $5.3M | 686k | 7.70 | |
| Theseus Pharmaceuticals | 0.3 | $5.2M | 892k | 5.80 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $5.0M | 1.3M | 4.02 | |
| Bcls Acquisition Corp Com Cl A | 0.3 | $5.0M | 500k | 10.02 | |
| Eqrx | 0.3 | $5.0M | 1.0M | 4.95 | |
| Panacea Acquisition Corp Ii Cl A Shs | 0.3 | $4.9M | 500k | 9.80 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.2 | $4.0M | 400k | 9.90 | |
| Dbv Technologies S A Sponsored Adr | 0.2 | $3.8M | 2.1M | 1.77 | |
| Atreca Cl A Com (BCEL) | 0.2 | $3.5M | 2.2M | 1.57 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $3.4M | 2.0M | 1.69 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $3.4M | 1.1M | 3.20 | |
| ZIOPHARM Oncology | 0.1 | $2.6M | 1.5M | 1.72 | |
| Gemini Therapeutics | 0.1 | $2.1M | 1.3M | 1.64 | |
| Omega Alpha Spac Cl A | 0.1 | $2.0M | 200k | 9.93 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $1.9M | 2.3M | 0.86 | |
| Mei Pharma Com New | 0.1 | $1.1M | 2.9M | 0.39 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $619k | 209k | 2.96 | |
| Codiak Biosciences | 0.0 | $382k | 488k | 0.78 | |
| Cabaletta Bio (CABA) | 0.0 | $351k | 540k | 0.65 | |
| Bellicum Pharmaceuticals Com New | 0.0 | $68k | 57k | 1.19 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $45k | 267k | 0.17 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $11k | 67k | 0.17 |